Pancreatic cancers are deadly and hard to treat, in part because they are so often detected at an advanced stage; overall five-year survival rates are about 11%. Two separate labs at Boston Children’s Hospital took out-of-the-box approaches to this difficult cancer, and both uncovered some very promising leads.
One-minute visual fixation can identify patients with schizophrenia
In a study published online in the Schizophrenia Bulletin, researchers from Dr. Wang Wei’s lab at the Center for Excellence in Brain Science and Intelligence Technology of the Chinese Academy of Sciences, and Dr. Wang Jijun’ team at Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, demonstrated spatial and temporal abnormalities of spontaneous fixational saccades and their correlates with positive and cognitive symptoms in schizophrenia, suggesting that fixational saccades are a promising and easily obtainable biomarker for cognitive and positive symptoms and for complementary diagnosis in schizophrenia.
App may help improve patient care through access to tests for cognition, motor, sensation and emotion
An iPad app developed at Northwestern Medicine that helps measure specific aspects of cognitive, motor, sensory and emotional function in five minutes or less is now available for doctors to screen people ages 3 to 85 years and beyond for a wide range of neurological diseases and syndromes.
Study shows promising results for immunotherapy targeting skin cancer
A new class of immunotherapy shows promising results for fighting the most aggressive form of skin cancer.
Mechanism of PTEN deficient breast cancer detailed, suggesting improved therapeutics
A group of researchers led by the Dana-Farber Cancer Institute, Boston, has illustrated the mechanistic pathway for PTEN-deficient breast cancer and successfully tested a method of countering the downstream effects of immune system evasion by tumors.
Global prevalence of H. pylori infection has steadily declined over 40 years
A research team led by Professor Leung Wai-keung from Department of Medicine, School of Clinical Medicine, LKS Faculty of Medicine, the University of Hong Kong (HKUMed) and the Baylor College of Medicine of the United States found that Helicobacter pylori (H. pylori) infection around the world has been steadily declining over the past four decades, thus offering a comprehensive, updated epidemiology of H. pylori infection. The study has been published in The Lancet Gastroenterology & Hepatology.
Research reveals brain pathway that signals when we have made a mistake and facilitates better future decision-making
The Nobel prize winning physicist Niels Bohr once said, “An expert is a (person) that has made all the mistakes that can be made in a narrow field.” This idea, that to master a skill we must learn from our mistakes and avoid making them in future, has long been recognized; however, the brain mechanisms and pathways that control this ability have been poorly understood.
Former DMMU National Coordinator Chanda Kabwe appears before police on allegations of being in possession of stolen property
FORMER Disaster Management and Mitigation Unit (DMMU) National Coordinator Chanda Kabwe has appeared before the police on allegations of being in possession of property believed to have been stolen. Mr Kabwe of Lusaka’s New Kasama area has since been issued with a Warn and caution statement involving allegations over a stolen motor vehicle. Deputy police […]
How the brain controls blood flow during sleep
Even while we are asleep, the brain does not rest completely. Surprisingly, the blood flow in a sleeping brain can be greater than when it is in a wakeful state. This allows the brain to remove waste metabolites, which is important to prevent the development and progression of neurological dysfunctions such as dementia. However, the exact mechanism of how the sleeping brain increases blood flow has not been known.
Drugmaker GSK says EU to review womb cancer treatment
British pharmaceutical giant GSK said on Tuesday that the EU’s drug watchdog will study a new treatment for a common type of womb cancer for potential approval in the European market.